Merck, 1046330500, Hypophosphorous acid 50%

Application

One-Pot Synthesis and in Silico Molecular Docking Studies of Arylselanyl Hydrazides as Potential Antituberculosis Agents.: This research illustrates the utilization of 50% Hypophosphorous acid in the synthesis of arylselanyl hydrazides, emphasizing its role as a reducing agent to facilitate novel antituberculosis compounds, reflecting its significance in medicinal chemistry applications (Borges et al., 2022).

Formation of Thick Aminophenyl Films from Aminobenzenediazonium Ion in the Absence of a Reduction Source.: This study explores the action of 50% Hypophosphorous acid in the spontaneous formation of aminophenyl films from diazonium ions without additional reducing agents, highlighting its potential in surface coating processes (Simons et al., 2014).

Analysis Note
Assay (alkalimetric): ≥ 49.5 %
Phosphorous acid and phosphoric acid (as H₃PO₃): ≤ 2
Chloride (Cl): ≤ 0.015 %
Total sulfur (as SO₄): ≤ 0.02 %
As (Arsenic): ≤ 0.0005 %
Ba (Barium): ≤ 0.005 %
Ca (Calcium): ≤ 0.005 %
Cd (Cadmium): ≤ 0.0001 %
Cu (Copper): ≤ 0.0005 %
Fe (Iron): ≤ 0.005 %
K (Potassium): ≤ 0.001 %
Mn (Manganese): ≤ 0.0005 %
Na (Sodium): ≤ 0.10 %
Ni (Nickel): ≤ 0.0005 %
Pb (Lead): ≤ 0.0005 %
Zn (Zinc): ≤ 0.0001 %
Legal Information
EMSURE is a registered trademark of Merck KGaA, Darmstadt, Germany